SCHEMBL1687280

SCHEMBL1687280

COc1cccc(-c2cc3ccc(O)cc3c(=O)n2CC(=O)NC(C)C)n1

nearest known ligand 0.41

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
AVPR1B P47901 16/20 0.41
TP53 P04637 1/20 0.38
CNR2 P34972 1/20 0.37
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1687140 0.82 AVPR1B (0.51) AVPR1BTP53
SCHEMBL1687360 0.81 AVPR1B (0.61) AVPR1B
SCHEMBL1687230 0.81 AVPR1B (0.48) AVPR1BCNR2
SCHEMBL1687403 0.77 AVPR1B (0.53) AVPR1B
SCHEMBL1687300 0.77 AVPR1B (0.51) AVPR1B
SCHEMBL1687282 0.77 AVPR1B (0.49) AVPR1BCNR2
SCHEMBL16423646 0.77 AVPR1B (0.45) AVPR1BTP53KDM4EALDH1A1
SCHEMBL1687309 0.72 AVPR1B (0.51) AVPR1B
SCHEMBL15136988 0.72 AVPR1B (0.48) AVPR1BTP53KDM4EALDH1A1
SCHEMBL1687136 0.71 AVPR1B (0.52) AVPR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2066640-B1 2-(1-OXO-1H-ISOQUINOLIN-2-YL) ACETAMIDE DERIVATIVES ORGANON NV (NL) 2011-09-07 EP disclosed
US-7906504-B2 N-tert-Butyl-2-[3-(4-fluoro-3-methoxyphenyl)-1-oxo-7-(3-pyrrolidin-1-ylpropoxy)-1H-isoquinolin-2-yl]acetamide; 2-[3-(3-Chlorophenyl)-7-((S)-2-methyl-3-pyrrolidin-1-ylpropoxy)-1-oxo-1H-isoquinolin-2-yl]-N-isopropylacetamide; antidepressants; hypothalamo-pituitary-adrenal axis modulators N.V. ORGANON (NL) 2011-03-15 US disclosed
US-20080064678-A1 2-(1-OXO-1H-ISOQUINOLIN-2-YL)ACETAMIDE DERIVATIVES N.V. ORGANON (NL) 2008-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064678-A1 2-(1-OXO-1H-ISOQUINOLIN-2-YL)ACETAMIDE DERIVATIVES SULT2A1, ACAT2, HDAC6 AVPR1B 1097/4885TP53 1031/4885CNR2 200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.